Prepared for Healthylife · September 2026

Access for women.
Evidence for everyone.

An opportunity to support a major maternal health initiative: giving women access to pregnancy and breastfeeding support, while helping establish an independently governed research program that measures what actually happens to them over time.

A mother breastfeeding her baby

The problem

Most women do not feed their baby the way, or for as long, as they intended.

96%of Australian women start breastfeeding
15%are still exclusively breastfeeding at five months

The distance between those two numbers is not a matter of choice. It is a matter of preparation, support, and of when that support arrives.

Australia is not an outlier. Across the Western world the shape of this is the same: almost every woman starts, and most stop long before she meant to.

Source: 2010 Australian National Infant Feeding Survey, the only dedicated national survey Australia has ever run. Sixteen years later, it has never been repeated.

A mother breastfeeding her newborn, held by her partner

The shift

The attention is shifting. The blueprint is written. Nobody is running it at scale.

Maternal health is finally being taken seriously. In September 2026, Olivia and Tom Walton committed an initial US$100 million to halve maternal deaths in the United States by 2031. Health systems, insurers and employers are moving in the same direction. This is good news, and it is overdue.

The research has already set out what good support looks like. Philips Avent and the UC San Diego Human Milk Institute published the specification in June: standalone tools do not work. What is needed is continuous, connected care that does not reset between pregnancy, hospital, home and the return to work.

Breastfeeding sits at the centre of both maternal and infant health. It appears twice in the fifteen-page plan behind that hundred million dollars.

The specification is written and we already run it. What is missing is the evidence at scale, and that is what Next 10,000 produces.

The opportunity

A large prospective cohort, measuring what women intend and what actually happens.

Ten thousand pregnant women, prepared before birth with The Thompson Method and supported daily through My Milk Map. Within that cohort, the women in Australia who choose to take part form an implementation study, run under independent human research ethics approval.

Each woman is measured against her own stated intention rather than against other mothers, and followed for twelve months from birth. The result is a full year of prospective maternal and infant health data of a kind that does not currently exist in this country.

No woman will be enrolled in the research until ethics approval is granted.

A mother holding her baby

Why us

Fifty years of work, already done.

Dr Robyn Thompson with a mother and her baby

Dr Robyn Thompson PhD OAM, 1944 to 2025.

We are not starting from scratch. The Thompson Method began with Dr Robyn Thompson's PhD on nipple trauma, continued through the research programme at Mater Mothers' Hospital from which the method developed, and has been published twice. In Women and Birth in 2016, and independently by Allen and colleagues in the International Journal of Nursing Studies in 2023, across 13,667 mother and baby pairs. Professor Sue Kildea is a co-author across that body of work.

Then we implemented it. One hundred thousand women over eight years, with the support model rebuilt each year around what those women said they needed. My Milk Map is the result.

The method is proven. The delivery is proven. What has never been done is running both together, at scale, and measuring it properly.

The fit

Why this belongs with Healthylife.

These are already your customers

Pregnant women and new mothers already shop with you. They are being sold to in a category where almost nobody is supporting them. This is not an audience to acquire, it is one to serve.

It is already your stated position

The Living Healthy Report argues for shifting funding to emphasise prevention over cure, and for viewing health as an investment rather than an expense. The earliest and cheapest prevention window in a human life is the one currently missing from the four pillars.

An ecosystem approach, in your own words

The report calls for institutions outside traditional healthcare to pursue the opportunity, and for commercial, not-for-profit and government sectors to work together. This is exactly that, in a category nobody else is covering.

Evidence, not content

You publish a national health report built on real-world data. This would give you a chapter nobody else in Australia can write, built on prospective evidence rather than on recall.

What a partnership could support

Six components, not a fixed amount.

  • Participant access to the program, including women who could not otherwise take part
  • Establishment of the research cohort
  • Research infrastructure and data systems
  • Independent academic and statistical oversight
  • Participant follow-up across twelve months
  • Analysis and publication

A partnership could support one of these, several, or the initiative as a whole. We would rather understand what level of involvement makes sense for you than arrive with a fixed figure.

A mother holding her newborn in hospital, shortly after birth

What a partner receives

Recognition, reach, and results.

  1. Public recognition

    Named acknowledgement on the project platform and in project communications, as a supporter of independent maternal health research.

  2. Measurable community impact

    Aggregate reporting on the reach and impact your support enabled: how many women, where, and what changed for them.

  3. Access for women who would miss out

    Support that goes directly to women who would not otherwise receive the program.

  4. Association with the cohort

    Association with what would be one of the largest prospective maternal health cohorts ever run in Australia.

  5. Your channels, your story

    The opportunity to communicate the partnership through your own health, wellbeing and community channels.

  6. Briefings on findings

    Briefings on research findings as they become available, while remaining independent from the scientific process.

The reassurance

Recognition without influence.

Commercial funding of research is common and, provided it is transparent and appropriately managed, does not in itself impede ethics approval. The principles are straightforward: the funding relationship is disclosed, and the funder does not control the study design, the analysis, the interpretation, or the publication of results.

Built in from the start, because we have a commercial interest in the result and the Index will be making public arguments about data quality:

  • An independent academic lead and an independent statistician, neither employed by us
  • A statistical analysis plan published before data collection begins
  • Prospective registration, lodged before recruitment
  • Independent human research ethics approval before any woman is enrolled
  • Results published whatever they show

A partner can be recognised as a funder without controlling what the research finds or how it is reported. That separation is what makes the recognition worth having.

The conversation we would like to have.

Not a fixed proposal. We would like to understand whether this is the kind of initiative you would want to be part of, and what level of involvement would make sense. We can build the right partnership around that.

Joanne Thompson, Custodian and CEO, The Thompson Method Group